Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

It is currently being developed by AstraZeneca and Avillion in the US under the terms of an agreement signed in 2018. Researchers evaluated the time it took for patients to experience severe ...

So on that note, Avillion Berhad (KLSE:AVI) looks quite promising in regards to its trends of return on capital. If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit ...